4.0 Article

Immunohistochemical analysis of tumor budding as predictor of lymph node metastasis from superficial esophageal squamous cell carcinoma

Journal

ESOPHAGUS
Volume 17, Issue 2, Pages 168-174

Publisher

SPRINGER JAPAN KK
DOI: 10.1007/s10388-019-00698-5

Keywords

Tumor budding; Immunohistochemistry; Esophageal squamous cell carcinoma; Lymph node metastasis

Ask authors/readers for more resources

Background Tumor budding is known predictors of lymph node metastasis from esophageal squamous cell carcinoma. However, it is not easy to detect such small cell clusters on hematoxylin-eosin (HE) staining. Therefore, we evaluated tumor budding using immunohistochemistry (IHC) for epithelial cell markers. Method We analyzed tumor budding in 50 cases of superficial esophageal squamous cell carcinoma. We evaluated the impact of clinicopathological factors and tumor budding to predict lymph node metastasis. A total of 565 tumor sections were assessed using HE staining and IHC for cytokeratin 5/6. Results Based on receiver operating characteristic curves, the cut-off values for high-grade tumor budding evaluated using HE staining or IHC were 2 and 11, respectively. High-grade tumor budding evaluated using HE staining (P = 0.007) and IHC (P <= 0.001) were significantly correlated with lymph node metastasis. For tumors with pT1a-MM to pT1b-SM1, high-grade tumor budding evaluated using IHC was correlated with lymph node metastasis (P = 0.050). Conclusions Tumor budding was significantly associated with lymph node metastasis. The optimal cut-off values of tumor budding on HE staining and tumor budding on IHC were 2 and 11, respectively. Even though both tumor budding on HE staining and tumor budding on IHC were significantly associated with lymph node metastasis, tumor budding on IHC tend to be more associated with lymph node metastasis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Predicting short-term life expectancy of patients with end-stage gastric cancer using Onodera's prognostic nutritional index

Kirika Oyama, Mari Oba, Yoko Oshima, Hideaki Shimada

Summary: The study found that O-PNI can be used to predict short-term life expectancy in patients with end-stage gastric cancer, with O-PNI decreasing as life expectancy shortens. Different optimal cutoff values for O-PNI were identified for 8, 4, and 1 week before death.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2021)

Review Surgery

Surgeon fatigue does not affect surgical outcomes: a systematic review and meta-analysis

Naoya Koda, Yoko Oshima, Keiji Koda, Hideaki Shimada

Summary: The study concluded that surgeon fatigue does not significantly affect postoperative mortality rates or total postoperative complication rates after elective surgeries, and may have minimal to no effect on postoperative mortality rates or total postoperative complication rates after non-elective surgeries.

SURGERY TODAY (2021)

Editorial Material Oncology

ASO Author Reflections: New Assay System to Detect Serum Anti-p53 Antibodies

Hideaki Shimada

ANNALS OF SURGICAL ONCOLOGY (2021)

Article Oncology

Anti-FIRΔexon2 autoantibody as a novel indicator for better overall survival in gastric cancer

Sohei Kobayashi, Takaki Hiwasa, Takayuki Ishige, Masayuki Kano, Tyuji Hoshino, Bahityar Rahmutulla, Masanori Seimiya, Hideaki Shimada, Fumio Nomura, Hisahiro Matsubara, Kazuyuki Matsushita

Summary: This study found that the detection of anti-FIR Delta exon2 Abs in gastric cancer patients may serve as a potential biomarker for monitoring a better prognosis, with high levels of anti-FIR Delta exon2 Abs significantly associated with overall survival.

CANCER SCIENCE (2021)

Article Oncology

Multipanel assay of 17 tumor-associated antibodies for serological detection of stage 0/I breast cancer

Makoto Sumazaki, Hideaki Ogata, Yoshihiro Nabeya, Akiko Kuwajima, Takaki Hiwasa, Hideaki Shimada

Summary: Tumor-associated antibodies (TAA) can be detected in cancer patients, including those with early-stage tumors. Different TAA showed varying positive rates, with non-luminal type breast cancer patients having significantly higher positivity rates. TAA may be useful for early detection of breast cancer.

CANCER SCIENCE (2021)

Article Oncology

Colorectal Cancer-Derived CAT1-Positive Extracellular Vesicles Alter Nitric Oxide Metabolism in Endothelial Cells and Promote Angiogenesis

Atsushi Ikeda, Satoshi Nagayama, Makoto Sumazaki, Makoto Konishi, Risa Fujii, Naomi Saichi, Satoshi Muraoka, Daisuke Saigusa, Hideaki Shimada, Yoshiharu Sakai, Koji Ueda

Summary: This study explores the proteomic information of colorectal cancer-derived TE-EVs, identifying CAT1 as a potential biomarker for colorectal cancer and emphasizing its role in tumor angiogenesis.

MOLECULAR CANCER RESEARCH (2021)

Article Surgery

Prognostic impact of CEA/CA19-9 at the time of recurrence in patients with gastric cancer

Jin Moriyama, Yoko Oshima, Tatsuki Nanami, Takashi Suzuki, Satoshi Yajima, Fumiaki Shiratori, Kimihiko Funahashi, Hideaki Shimada

Summary: This study evaluated the clinical impact of CEA and CA19-9 values at the time of recurrence in gastric cancer patients. The results suggest that CA19-9 positive status at recurrence may have a negative prognostic impact, particularly in patients with lymph node recurrence.

SURGERY TODAY (2021)

Article Gastroenterology & Hepatology

Preoperative low serum creatine kinase is associated with poor overall survival in the male patients with esophageal squamous cell carcinoma

Kenji Murayama, Takashi Suzuki, Satoshi Yajima, Yoko Oshima, Tatsuki Nanami, Fumiaki Shiratori, Hideaki Shimada

Summary: This study analyzed the prognostic significance of preoperative serum creatine kinase level in patients with esophageal squamous cell carcinoma. The results showed that low serum creatine kinase level was associated with worse overall survival in male patients with esophageal squamous cell carcinoma.

ESOPHAGUS (2022)

Article Oncology

Presence of serum RalA and serum p53 autoantibodies in 1833 patients with various types of cancers

Tatsuki Nanami, Isamu Hoshino, Fumiaki Shiratori, Satoshi Yajima, Yoko Oshima, Takashi Suzuki, Masaaki Ito, Takaki Hiwasa, Akiko Kuwajima, Hideaki Shimada

Summary: The study found that the levels of s-RalA-Abs and s-p53-Abs were significantly elevated in various types of cancer, with positivity rates of both antibodies above 20%. The two antibodies were complementary in prostate and breast cancers, but independent in other carcinomas.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2022)

Editorial Material Gastroenterology & Hepatology

Real-World Data Related to the Topics of 6th Edition of Gastric Cancer Treatment Guidelines

Hideaki Shimada

ANNALS OF GASTROENTEROLOGICAL SURGERY (2021)

Article Oncology

Novel cancer-specific epidermal growth factor receptor antibody obtained from the serum of esophageal cancer patients with long-term survival

Sayaka Takagi-Maeda, Satoshi Yajima, Takashi Suzuki, Katsuaki Usami, Nobuaki Takahashi, Rinpei Niwa, Hideaki Shimada

Summary: An antibody KT112 specifically binding to cancer cells has been identified, showing potential tumor suppression effects on esophageal cancer patients due to its high cancer specificity.

CANCER SCIENCE (2022)

Article Surgery

Prognostic significance of preoperative low serum creatine kinase levels in gastric cancer

Nobuto Yamazaki, Yoko Oshima, Fumiaki Shiratori, Tatsuki Nanami, Takashi Suzuki, Satoshi Yajima, Kimihiko Funahashi, Hideaki Shimada

Summary: This study evaluated the clinicopathological and prognostic significance of preoperative serum creatine kinase (CK) levels in gastric cancer. The results showed that low CK levels were predictive of poor survival in men with gastric cancer, but not in women.

SURGERY TODAY (2022)

Review Oncology

Systematic review and meta-analysis of reports of patients with gastric cancer aged 80 years and older

Chihiro Onagi, Mari Oba, Yoko Oshima, Hideaki Shimada

Summary: The number of elderly patients undergoing gastric cancer surgery is increasing, and this study aimed to analyze the prognosis of patients aged 80 years or older. The study found that elderly patients with gastric cancer who underwent radical surgery had a 5-year survival rate of up to 57%, and postoperative complications appeared to have a minor impact.

INTERNATIONAL CANCER CONFERENCE JOURNAL (2022)

Review Gastroenterology & Hepatology

Clinical TNM staging for esophageal, gastric, and colorectal cancers in the era of neoadjuvant therapy: A systematic review of the literature

Hideaki Shimada, Takeo Fukagawa, Yoshio Haga, Shin-ichi Okazumi, Koji Oba

Summary: Clinical staging is crucial for advanced tumors treatment strategies. PET-CT and/or MRI are best for assessing distant metastases in gastrointestinal cancers. Different types of gastrointestinal cancers may require different diagnostic algorithms for clinical staging.

ANNALS OF GASTROENTEROLOGICAL SURGERY (2021)

Article Oncology

Possible predictive significance of serum RalA autoantibodies on relapse-free survival in patients with colorectal cancer

Mitsunori Ushigome, Hideaki Shimada, Yoshihiro Nabeya, Fumiaki Shiratori, Hiroaki Soda, Nobuhiro Takiguchi, Isamu Hoshino, Akiko Kuwajima, Tomoaki Kaneko, Kimihiko Funahashi

Summary: The study investigated the clinical and prognostic significance of s-RalA-Abs in patients with colorectal cancer. The presence of s-RalA-Abs was not significantly associated with clinicopathological characteristic factors, but it was found to be a useful predictor of poor relapse-free survival in patients with colorectal cancer, especially in those with a positive CEA status.

MOLECULAR AND CLINICAL ONCOLOGY (2021)

No Data Available